Evocalcet

CAS No. 870964-67-3

Evocalcet( KHK7580 )

Catalog No. M22494 CAS No. 870964-67-3

Evocalcet has an activating effect on the calcium-sensing receptor (CaSR).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 32 In Stock
5MG 29 In Stock
10MG 46 In Stock
25MG 88 In Stock
50MG 142 In Stock
100MG 217 In Stock
200MG 315 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Evocalcet
  • Note
    Research use only, not for human use.
  • Brief Description
    Evocalcet has an activating effect on the calcium-sensing receptor (CaSR).
  • Description
    Evocalcet has an activating effect on the calcium-sensing receptor (CaSR).
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male Sprague Dawley chronic kidney disease (CKD) rats with adenine induced secondary hyperparathyroidism (SHPT)Dosage:0.03 and 0.3 mg/kg Administration:Oral Administration; 0.03 and 0.3 mg/kg, once Result:Decreased the serum PTH and Ca levels at a dose of 0.3 mg/kg.
  • Synonyms
    KHK7580
  • Pathway
    GPCR/G Protein
  • Target
    CaSR
  • Recptor
    CaSR
  • Research Area
    Cancer
  • Indication
    Parathyroid CarcinomaPrimary Hyperparathyroidism

Chemical Information

  • CAS Number
    870964-67-3
  • Formula Weight
    374.48
  • Molecular Formula
    C24H26N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:30 mg/mL (80.11 mM; Need ultrasonic and warming)
  • SMILES
    C[C@@H](N[C@H]1CCN(C1)c1ccc(CC(O)=O)cc1)c1cccc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tanimura, Shinji, et al. Pharmaceutical composition containing aryl alkyl amine compound. WO 2017061621 A1.
molnova catalog
related products
  • Strontium ranelate

    A strontium(II) salt of ranelic acid that stimulates CaSR and leads to the differentiation of pre-osteoblast to osteoblast, increases the bone formation; also stimulates osteoblasts to secrete osteoprotegerin in inhibiting osteoclasts formed from pre-osteoclasts in relation to the RANKL system.

  • CaSR-IN-10a

    A potent CaSR antagonist with IC50 of 4.4 nM in CaSR FLIPR assay.

  • GSK3004774

    GSK3004774 (GSK-3004774) is a potent, nonabsorbable, gastrointestinally-restricted agonist agonist of calcium-sensing receptor (CaSR) with pEC50 of 7.3.